20.05
price down icon11.01%   -2.145
 
loading
전일 마감가:
$22.20
열려 있는:
$23.06
하루 거래량:
58,930
Relative Volume:
0.63
시가총액:
$776.97M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-17.69%
1개월 성능:
-35.21%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
Value
$19.84
$23.79
1주일 범위
Value
$19.57
$25.04
52주 변동 폭
Value
$19.57
$31.13

Oruka Therapeutics Inc Stock (ORKA) Company Profile

Name
명칭
Oruka Therapeutics Inc
Name
전화
650-606-7910
Name
주소
855 OAK GROVE AVE., MENLO PARK
Name
직원
0
Name
트위터
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
ORKA's Discussions on Twitter

ORKA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
ORKA 20.29 776.97M 0 0 0 0.00
VRTX 448.36 115.74B 10.63B -479.80M -1.35B 13.33
REGN 746.76 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 590.80 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.12 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.98 24.49B 3.30B -501.07M 1.03B 11.54

Oruka Therapeutics Inc 주식(ORKA)의 최신 뉴스

pulisher
Nov 19, 2024

Oruka Therapeutics to Present at Piper Sandler's 36th Annual Healthcare Conference - The Manila Times

Nov 19, 2024
pulisher
Nov 19, 2024

Oruka Therapeutics to Present at Piper Sandler Healthcare Conference | Psoriasis Drug Developer | ORKA Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 19, 2024

Oruka Therapeutics to Present at Piper Sandler’s 36th Annual Healthcare Conference - GlobeNewswire

Nov 19, 2024
pulisher
Nov 18, 2024

Oruka Therapeutics gains approval for preferred stock conversion - Investing.com

Nov 18, 2024
pulisher
Nov 16, 2024

Oruka Therapeutics adjusts financials post-merger By Investing.com - Investing.com Canada

Nov 16, 2024
pulisher
Nov 14, 2024

JANUS HENDERSON GROUP PLC Acquires New Stake in Oruka Therapeuti - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 13, 2024
pulisher
Nov 13, 2024

Oruka Therapeutics Raises $475M, Accelerates Clinical Timeline for Key Drug Programs | ORKA Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 04, 2024

Oruka Therapeutics to Present at Multiple November Investor Conferences - StockTitan

Nov 04, 2024
pulisher
Oct 11, 2024

Oruka stock draws buy rating at Stifel (NASDAQ:ORKA) - Seeking Alpha

Oct 11, 2024
pulisher
Oct 07, 2024

Oruka Therapeutics shares gain buy rating as H.C. Wainwright sees strong future in psoriasis treatment - Investing.com Canada

Oct 07, 2024
pulisher
Oct 04, 2024

Oruka Therapeutics Adjusts Executive Severance Agreements - TipRanks

Oct 04, 2024
pulisher
Sep 27, 2024

Oruka Therapeutics (NASDAQ:ORKA) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024
pulisher
Sep 25, 2024

Oruka shares rise as TD Cowen maintains buy on drug potential - Investing.com Canada

Sep 25, 2024
pulisher
Sep 25, 2024

Oruka Therapeutics reveals promising preclinical data for psoriasis treatment - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of ... - The Bakersfield Californian

Sep 25, 2024
pulisher
Sep 25, 2024

Oruka Therapeutics Announces Preclinical Data for ORKA-001 - GlobeNewswire

Sep 25, 2024
pulisher
Sep 25, 2024

Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress - StockTitan

Sep 25, 2024
pulisher
Sep 24, 2024

Ordell Minerals Advances Gold Prospects with Phase 2 Drilling - TipRanks

Sep 24, 2024
pulisher
Sep 24, 2024

Orkla ASA (OTCMKTS:ORKLY) Sets New 1-Year High at $9.47 - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Orgenesis announces reverse stock split to meet Nasdaq requirements By Investing.com - Investing.com Australia

Sep 24, 2024
pulisher
Sep 24, 2024

Orora (OTCMKTS:ORRYY) Shares Up 32.6% - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

Why Orgenesis (ORGS) Stock Is Down 23% Today - Benzinga

Sep 23, 2024
pulisher
Sep 23, 2024

‘Omni Loop’ takes a bit too much on its plate - Daily Trojan Online

Sep 23, 2024
pulisher
Sep 22, 2024

Private Auckland hospital doubles in size: New $3m robot, extra beds, surgical expansion - New Zealand Herald

Sep 22, 2024
pulisher
Sep 22, 2024

Organon: A Surprising Deal (NYSE:OGN) - Seeking Alpha

Sep 22, 2024
pulisher
Sep 21, 2024

‘Omni Loop’ (2024) Movie ReviewNothing New | MOVIESR.NET - Midgard Times

Sep 21, 2024
pulisher
Sep 21, 2024

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives $41.25 Average PT from Analysts - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

Halozyme's ENHANZE® (HALO) Technology Empowers OCREVUS ZUNOVO™: A New Era in MS Treatment - BP Journal

Sep 20, 2024
pulisher
Sep 19, 2024

Oruka Therapeutics (NASDAQ:ORKA) Coverage Initiated at Leerink Partners - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Research Analysts Offer Predictions for Oruka Therapeutics, Inc.’s Q3 2024 Earnings (NASDAQ:ORKA) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Oruka Therapeutics (NASDAQ:ORKA) Stock Rating Upgraded by Leerink Partnrs - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Ocugen Inc [OCGN] Stock bought by Insider RAMESH KUMAR for $0.15 million - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

‘Omni Loop’ Review: Sci-Fi Indie Offers Some Ham-Fisted Heart - Observer

Sep 18, 2024
pulisher
Sep 18, 2024

Lifesci Capital Initiates Coverage on Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

TD Cowen Initiates Coverage on Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

Leerink Partners starts drug developer Oruka with 'outperform' - XM

Sep 17, 2024
pulisher
Sep 17, 2024

Oruka Therapeutics initiated with an Outperform at Leerink - TipRanks

Sep 17, 2024
pulisher
Sep 16, 2024

Back-To-Back FDA Approvals For Roche's Two Under-The-Skin Injections - Benzinga

Sep 16, 2024
pulisher
Sep 16, 2024

Roche scores first, with FDA approval of Ocrevus Zunovo for MS - The Pharma Letter

Sep 16, 2024
pulisher
Sep 16, 2024

Analysts Issue Forecasts for Oruka Therapeutics, Inc.’s Q3 2024 Earnings (NASDAQ:ORKA) - Defense World

Sep 16, 2024
pulisher
Sep 16, 2024

FDA approves Roche’s Ocrevus Zunovo with Halozyme Enhanze delivery tech - Pharmaceutical Technology

Sep 16, 2024
pulisher
Sep 15, 2024

Oruka Therapeutics (NASDAQ:ORKA) Coverage Initiated at Jefferies Financial Group - Defense World

Sep 15, 2024
pulisher
Sep 13, 2024

Oruka Therapeutics Secures $200M to Advance Skin Disease Treatments - TipRanks

Sep 13, 2024
pulisher
Sep 13, 2024

FDA approves new multiple sclerosis treatment OCREVUS ZUNOVO By Investing.com - Investing.com Australia

Sep 13, 2024
pulisher
Sep 13, 2024

Halozyme Announces FDA Approval of Roche's Subcutaneous OCREVUS ZUNOVO™ with ENHANZE® for People with Relapsing and Primary Progressive Multiple Sclerosis - PR Newswire

Sep 13, 2024
pulisher
Sep 13, 2024

FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug - STAT

Sep 13, 2024
pulisher
Sep 13, 2024

Oruka to advance psoriasis programs into clinic next year - BioWorld Online

Sep 13, 2024
pulisher
Sep 12, 2024

Jefferies starts Oruka Therapeutics with buy, $40 target - Investing.com UK

Sep 12, 2024
pulisher
Sep 12, 2024

Biotech firm enters $200M agreement - The Business Journals

Sep 12, 2024
pulisher
Sep 12, 2024

Oruka Therapeutics secures $200 million in PIPE financing By Investing.com - Investing.com Canada

Sep 12, 2024

Oruka Therapeutics Inc (ORKA) 재무 분석

Oruka Therapeutics Inc (ORKA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Oruka Therapeutics Inc 주식 (ORKA) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
JANUS HENDERSON GROUP PLC
10% Owner
Jul 24 '24
Buy
3.20
189,856
606,873
2,081,168
JANUS HENDERSON GROUP PLC
10% Owner
Jul 25 '24
Buy
3.05
30,227
92,292
2,111,395
JANUS HENDERSON GROUP PLC
10% Owner
Jul 03 '24
Buy
3.55
166,042
589,565
1,648,577
JANUS HENDERSON GROUP PLC
10% Owner
Jul 11 '24
Buy
3.45
94,537
326,304
1,891,312
JANUS HENDERSON GROUP PLC
10% Owner
Jul 10 '24
Buy
3.46
55,463
192,130
1,796,775
JANUS HENDERSON GROUP PLC
10% Owner
Jul 08 '24
Buy
3.46
47,492
164,190
1,724,395
JANUS HENDERSON GROUP PLC
10% Owner
Jul 05 '24
Buy
3.43
28,326
97,065
1,676,903
JANUS HENDERSON GROUP PLC
10% Owner
Jul 09 '24
Buy
3.43
16,917
58,091
1,741,312
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):